EMPLOYMENT AGREEMENTEmployment Agreement • November 3rd, 2023 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 3rd, 2023 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (“Agreement”) is entered into as of October 30, 2023 by and between BioMarin Pharmaceutical Inc., a Delaware corporation (the “Company”) and Alexander Hardy (“Employee”).
SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement • November 3rd, 2023 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations
Contract Type FiledNovember 3rd, 2023 Company IndustryThis Separation Agreement and General Release (“Agreement”) dated October 30, 2023 is between Jean-Jacques Bienaime and BioMarin Pharmaceutical Inc., including any past or present parents, subsidiaries, affiliates, entities and divisions (collectively, the “Company”). The parties agree to the following:
CONSULTING AGREEMENTConsulting Agreement • November 3rd, 2023 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 3rd, 2023 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is entered into on October 30, 2023 to be effective December 1, 2023 (the “Effective Date”), and is made by and between BioMarin Pharmaceutical Inc., (“BioMarin”), a Delaware corporation, located at 105 Digital Drive, Novato, CA 94949, and Jean-Jacques Bienaime (“Provider”). BioMarin and Provider are each individually referred to herein as a “Party” and collectively as the “Parties”.